Class IIOngoing

Testosterone Gel recall

FDA recall D-0637-2024 · initiated Aug 8, 2024

May cause temporary or medically reversible harm; low probability of serious harm.

Why it was recalled

Superpotent Drug

Details

Product: Testosterone Gel, 1.62%, (Alcohol 80% v/v), 30 unit-dose packets, Rx Only, Teva Pharmaceuticals, USA, Inc. North Wales, PA 19454, NDC 0591-2925-30. Packet NDC # 0591-2925-32 Carton NDC # 0591-2925-30
Recalling company: Teva Pharmaceuticals USA, Inc.
Classification: Class II
Status: Ongoing
Type: Voluntary: Firm initiated
Distribution: Product was distributed nationwide within the United States
Initiated: Aug 8, 2024
FDA report date: Aug 28, 2024

What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.

Source: openFDA Drug Enforcement record D-0637-2024 ↗

← All drug recalls